Search

Nancy J. Leith

Examiner (ID: 12198, Phone: (313)446-4874 , Office: P/1636 )

Most Active Art Unit
1636
Art Unit(s)
1636, 1811, 1815, 1941, 1805
Total Applications
1445
Issued Applications
999
Pending Applications
194
Abandoned Applications
284

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 9957732 [patent_doc_number] => 09005935 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-14 [patent_title] => 'Methods and compositions for DNA fragmentation and tagging by transposases' [patent_app_type] => utility [patent_app_number] => 13/470087 [patent_app_country] => US [patent_app_date] => 2012-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 9954 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13470087 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/470087
Methods and compositions for DNA fragmentation and tagging by transposases May 10, 2012 Issued
Array ( [id] => 9635669 [patent_doc_number] => 20140213779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-31 [patent_title] => 'RIBOSWITCHES' [patent_app_type] => utility [patent_app_number] => 14/116727 [patent_app_country] => US [patent_app_date] => 2012-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 67 [patent_figures_cnt] => 67 [patent_no_of_words] => 25135 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14116727 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/116727
RIBOSWITCHES May 9, 2012 Abandoned
Array ( [id] => 9922620 [patent_doc_number] => 08980579 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-17 [patent_title] => 'Chromosomal landing pads and related uses' [patent_app_type] => utility [patent_app_number] => 13/440661 [patent_app_country] => US [patent_app_date] => 2012-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14316 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13440661 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/440661
Chromosomal landing pads and related uses Apr 4, 2012 Issued
Array ( [id] => 13237423 [patent_doc_number] => 10131903 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-20 [patent_title] => Microfluidic platform for synthetic biology applications [patent_app_type] => utility [patent_app_number] => 13/437727 [patent_app_country] => US [patent_app_date] => 2012-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 89 [patent_no_of_words] => 15907 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 267 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13437727 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/437727
Microfluidic platform for synthetic biology applications Apr 1, 2012 Issued
Array ( [id] => 10039478 [patent_doc_number] => 09080177 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-14 [patent_title] => 'pAVEC' [patent_app_type] => utility [patent_app_number] => 14/110217 [patent_app_country] => US [patent_app_date] => 2012-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9392 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14110217 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/110217
pAVEC Apr 1, 2012 Issued
Array ( [id] => 9294589 [patent_doc_number] => 20140038223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-06 [patent_title] => 'CRK-A NOVEL TARGET FOR CANCER THERAPY' [patent_app_type] => utility [patent_app_number] => 14/008032 [patent_app_country] => US [patent_app_date] => 2012-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6574 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008032 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/008032
CRK-A NOVEL TARGET FOR CANCER THERAPY Mar 29, 2012 Abandoned
Array ( [id] => 10019854 [patent_doc_number] => 09062326 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-23 [patent_title] => 'Expression vector for animal cells' [patent_app_type] => utility [patent_app_number] => 14/008286 [patent_app_country] => US [patent_app_date] => 2012-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 11133 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008286 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/008286
Expression vector for animal cells Mar 29, 2012 Issued
Array ( [id] => 9306588 [patent_doc_number] => 20140045262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'CONSTRUCTS AND METHOD FOR REGULATING GENE EXPRESSION OR FOR DETECTING AND CONTROLLING A DNA LOCUS IN EUKARYOTES' [patent_app_type] => utility [patent_app_number] => 14/006743 [patent_app_country] => US [patent_app_date] => 2012-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14586 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14006743 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/006743
Constructs and method for regulating gene expression or for detecting and controlling a DNA locus in eukaryotes Mar 22, 2012 Issued
Array ( [id] => 9294600 [patent_doc_number] => 20140038234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-06 [patent_title] => 'Expression System With Sar Element From IFNalpha2' [patent_app_type] => utility [patent_app_number] => 14/110944 [patent_app_country] => US [patent_app_date] => 2012-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5259 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14110944 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/110944
Expression system with SAR element from IFNα2 Mar 19, 2012 Issued
Array ( [id] => 11874708 [patent_doc_number] => 09746475 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-29 [patent_title] => 'Antibody and antibody mimetic for visualization and ablation of endogenous proteins' [patent_app_type] => utility [patent_app_number] => 14/004879 [patent_app_country] => US [patent_app_date] => 2012-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 20376 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14004879 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/004879
Antibody and antibody mimetic for visualization and ablation of endogenous proteins Mar 12, 2012 Issued
Array ( [id] => 10142528 [patent_doc_number] => 09175331 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-03 [patent_title] => 'Inhibitors of human EZH2, and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 13/418242 [patent_app_country] => US [patent_app_date] => 2012-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 51621 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 182 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13418242 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/418242
Inhibitors of human EZH2, and methods of use thereof Mar 11, 2012 Issued
Array ( [id] => 8278362 [patent_doc_number] => 20120172236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'Selection and Enrichment of Proteins Using In Vitro Compartmentalization' [patent_app_type] => utility [patent_app_number] => 13/415504 [patent_app_country] => US [patent_app_date] => 2012-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11088 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13415504 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/415504
Selection and enrichment of proteins using in vitro compartmentalization Mar 7, 2012 Issued
Array ( [id] => 12254463 [patent_doc_number] => 09926601 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-27 [patent_title] => 'Alternatively spliced mRNA isoforms as prognostic indicators for metastatic cancer' [patent_app_type] => utility [patent_app_number] => 14/000995 [patent_app_country] => US [patent_app_date] => 2012-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 35103 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 251 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14000995 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/000995
Alternatively spliced mRNA isoforms as prognostic indicators for metastatic cancer Feb 23, 2012 Issued
Array ( [id] => 9306502 [patent_doc_number] => 20140045176 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'METHOD FOR CONCENTRATING CELLS THAT ARE GENETICALLY ALTERED BY NUCLEASES' [patent_app_type] => utility [patent_app_number] => 14/000920 [patent_app_country] => US [patent_app_date] => 2012-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 16366 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14000920 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/000920
Method for concentrating cells that are genetically altered by nucleases Feb 21, 2012 Issued
Array ( [id] => 9212524 [patent_doc_number] => 20140011701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-09 [patent_title] => 'Prognostic Marker Sets For Prostate Cancer' [patent_app_type] => utility [patent_app_number] => 14/004507 [patent_app_country] => US [patent_app_date] => 2012-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5049 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14004507 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/004507
Prognostic Marker Sets For Prostate Cancer Feb 15, 2012 Abandoned
Array ( [id] => 8394123 [patent_doc_number] => 20120231965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-13 [patent_title] => 'DRUG SELECTION FOR COLORECTAL CANCER THERAPY USING ANTIBODY-BASED ARRAYS' [patent_app_type] => utility [patent_app_number] => 13/365638 [patent_app_country] => US [patent_app_date] => 2012-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 30841 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13365638 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/365638
DRUG SELECTION FOR COLORECTAL CANCER THERAPY USING ANTIBODY-BASED ARRAYS Feb 2, 2012 Abandoned
Array ( [id] => 9134863 [patent_doc_number] => 20130295578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-07 [patent_title] => 'METHODS FOR SCREENING FOR DRUG RESISTANCE IN CANCER TREATMENT' [patent_app_type] => utility [patent_app_number] => 13/978724 [patent_app_country] => US [patent_app_date] => 2012-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6644 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13978724 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/978724
METHODS FOR SCREENING FOR DRUG RESISTANCE IN CANCER TREATMENT Jan 9, 2012 Abandoned
Array ( [id] => 9850063 [patent_doc_number] => 08951790 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-10 [patent_title] => 'Mammalian expression vector pUHAB' [patent_app_type] => utility [patent_app_number] => 13/344905 [patent_app_country] => US [patent_app_date] => 2012-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 4 [patent_no_of_words] => 6309 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13344905 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/344905
Mammalian expression vector pUHAB Jan 5, 2012 Issued
Array ( [id] => 9269636 [patent_doc_number] => 20140024554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-23 [patent_title] => 'COMPLEX SETS OF MIRNAS AS NON-INVASIVE BIOMARKERS FOR GLIOBLASTOMA' [patent_app_type] => utility [patent_app_number] => 13/995956 [patent_app_country] => US [patent_app_date] => 2011-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 23115 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13995956 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/995956
COMPLEX SETS OF MIRNAS AS NON-INVASIVE BIOMARKERS FOR GLIOBLASTOMA Dec 27, 2011 Abandoned
Array ( [id] => 9120891 [patent_doc_number] => 20130287814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'DNA Expression Construct' [patent_app_type] => utility [patent_app_number] => 13/996829 [patent_app_country] => US [patent_app_date] => 2011-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4725 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13996829 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/996829
DNA Expression Construct Dec 22, 2011 Abandoned
Menu